The PAR-6/aPKC Polarity Complex in Synaptic Assembly and Function

突触组装和功能中的 PAR-6/aPKC 极性复合体

基本信息

  • 批准号:
    7642842
  • 负责人:
  • 金额:
    $ 9万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This proposal is based on the finding that the PAR-6/aPKC polarity complex regulates dendritic spine morphogenesis, and that it does so through a novel pathway involving p190 RhoGAP and the RhoA GTPase. My goal during the mentored phase of this proposal is to learn electrophysiological approaches required to address whether the PAR-6/aPKC complex regulates synaptic function, and to extend my studies to an in vivo environment by generating a conditional PAR-6 knockout mouse. I will also learn the. mouse behavioral approaches to incoporate into my future research. The mentored phase research will be carried out in the University of Virginia. I will be mentored by Dr. Ian Macara (primary mentor), Dr. Suzanne Moenter (co-mentor), Dr. Julius Zhu and Dr. Scott Zeitlin (mentoring committee members). For the independent phase, I will continue to explore the function of the PAR-6/aPKC complex in synaptic assembly and function, both in dissociated neuronal cultures and in vivo. The specific questions that I would like to address during this phase are: What are the upstream regulators of the PAR-6/aPKC complex? What is the molecular basis for the activation of p190 RhoGAP by PAR-6/aPKC? Is PAR-6 involved in synaptic plasticity and memory formation in vivo? Together, these studies will provide significant insight into the role of the PAR-6/aPKC complex in regulating synaptic function. My long term goal is to understand the complex signaling mechanisms regulating synaptic assembly and function, and how they relate to memory formation in vivo. I will use a combination of cell biological, electrophysiological and behavioral approaches to address these questions. PUBLIC HEALTH RELEVANCE: The goal of this research proposal is to understand the effects of a group of proteins called PAR-6 and aPKC on the way brain cells connect with each other. The results can have significant implications in various neurological disorders including mental retardation, schizophrenia and Alzheimer's disease.
这一建议是基于PAR-6/aPKC极性复合物调节树突棘形态发生的发现,并且它是通过一个涉及p190 RhoGAP和RhoA GTPase的新途径来实现的。在本提案的指导阶段,我的目标是学习解决PAR-6/aPKC复合体是否调节突触功能所需的电生理学方法,并通过生成条件PAR-6敲除小鼠将我的研究扩展到体内环境。我也将学习。将老鼠行为方法纳入我未来的研究。指导阶段的研究将在弗吉尼亚大学进行。我将由Ian Macara博士(主要导师),Suzanne Moenter博士(联合导师),Julius Zhu博士和Scott Zeitlin博士(指导委员会成员)指导。对于独立阶段,我将继续探索PAR-6/aPKC复合物在分离神经元培养物和体内突触组装和功能中的功能。在这个阶段,我想解决的具体问题是:PAR-6/aPKC复合体的上游调节因子是什么?PAR-6/aPKC激活p190 RhoGAP的分子基础是什么?PAR-6在体内是否参与突触可塑性和记忆形成?总之,这些研究将为PAR-6/aPKC复合物在调节突触功能中的作用提供重要的见解。我的长期目标是了解调节突触组装和功能的复杂信号机制,以及它们与体内记忆形成的关系。我将结合细胞生物学、电生理学和行为学的方法来解决这些问题。公共卫生相关性:这项研究计划的目标是了解一组名为PAR-6和aPKC的蛋白质对脑细胞相互连接方式的影响。这一结果可能对包括智力迟钝、精神分裂症和阿尔茨海默病在内的各种神经系统疾病具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huaye Zhang其他文献

Huaye Zhang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Huaye Zhang', 18)}}的其他基金

MARK1 in dendritic spine neoteny
树突棘幼态持续中的 MARK1
  • 批准号:
    10753728
  • 财政年份:
    2023
  • 资助金额:
    $ 9万
  • 项目类别:
Shank3 and the Par polarity complex in neurodevelopmental disorders
Shank3 和 Par 极性复合体在神经发育障碍中的作用
  • 批准号:
    10390824
  • 财政年份:
    2021
  • 资助金额:
    $ 9万
  • 项目类别:
Polarity determinants in endolysosomal trafficking and proteostasis: Implications for Alzheimer's disease pathogenesis
内溶酶体运输和蛋白质稳态中的极性决定因素:对阿尔茨海默病发病机制的影响
  • 批准号:
    9912086
  • 财政年份:
    2019
  • 资助金额:
    $ 9万
  • 项目类别:
Polarity determinants in synaptic stability and plasticity
突触稳定性和可塑性的极性决定因素
  • 批准号:
    9102286
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Polarity determinants in synaptic stability and plasticity
突触稳定性和可塑性的极性决定因素
  • 批准号:
    9298710
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
Polarity determinants in synaptic stability and plasticity
突触稳定性和可塑性的极性决定因素
  • 批准号:
    8964142
  • 财政年份:
    2015
  • 资助金额:
    $ 9万
  • 项目类别:
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and Function
突触组装和功能中的 PAR-6/aPKC 极性复合体
  • 批准号:
    8704179
  • 财政年份:
    2009
  • 资助金额:
    $ 9万
  • 项目类别:
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and Function
突触组装和功能中的 PAR-6/aPKC 极性复合体
  • 批准号:
    8414161
  • 财政年份:
    2009
  • 资助金额:
    $ 9万
  • 项目类别:
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and Function
突触组装和功能中的 PAR-6/aPKC 极性复合体
  • 批准号:
    8203101
  • 财政年份:
    2009
  • 资助金额:
    $ 9万
  • 项目类别:
The PAR-6/aPKC Polarity Complex in Synaptic Assembly and Function
突触组装和功能中的 PAR-6/aPKC 极性复合体
  • 批准号:
    8209063
  • 财政年份:
    2009
  • 资助金额:
    $ 9万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 9万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了